Synthesis of Gentamicin (cas 1403-66-3)-grafted-chitosan with improved solubility and antibacterial activity
-
Add time:09/07/2019 Source:sciencedirect.com
Due to superior properties, chitosan (CS) has been widely applied in health field. However its acid-solubility and poor antimicrobial activity compromise its safety and applications, respectively. To enhance its water-solubility and antimicrobial activity, gentamicin-grafted-chitosan (GT-CS) is synthesized for the first time, which is then confirmed by various characteristic methods and the graft ratio for gentamicin is about 22.1%. Particularly, it is the first study, disclosing there are degradation and crosslinking involved simultaneously during CS oxidation. Furthermore, GT-CS shows greatly improved water solubility (10.0w%). Compared to CS, the antibacterial activity of GT-CS is improved significantly, approaching the pure gentamicin. It should be noted that the antimicrobic mechanism may not be the target-specific interactions but the nonspecific interactions with the bacterial membrane as shown by scanning electron microscope. To sum up, GT-CS is a superior antimicrobial with good solubility.
We also recommend Trading Suppliers and Manufacturers of Gentamicin (cas 1403-66-3). Pls Click Website Link as below: cas 1403-66-3 suppliers
Prev:Controllable delivery from Gentamicin (cas 1403-66-3) loaded polycaprolactone/grafted silica nanoparticles composite mats
Next:Microbicidal Gentamicin (cas 1403-66-3)-alginate hydrogels) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research paperEvaluation of collagen/hydroxyapatite electrospun layers loaded with vancomycin, Gentamicin (cas 1403-66-3) and their combination: Comparison of release kinetics, antimicrobial activity and cytocompatibility09/10/2019
- Electrospinning of silica nanoparticles-entrapped nanofibers for sustained Gentamicin (cas 1403-66-3) release09/09/2019
- Microbicidal Gentamicin (cas 1403-66-3)-alginate hydrogels09/08/2019
- Controllable delivery from Gentamicin (cas 1403-66-3) loaded polycaprolactone/grafted silica nanoparticles composite mats09/06/2019
- Improving Gentamicin (cas 1403-66-3) B and Gentamicin (cas 1403-66-3) C1a production by engineering the glycosyltransferases that transfer primary metabolites into secondary metabolites biosynthesis09/05/2019
- Original articleEffect of Withania somnifera on Gentamicin (cas 1403-66-3) induced renal lesions in rats09/04/2019
- Intratympanic mixture Gentamicin (cas 1403-66-3) and dexamethasone versus dexamethasone for unilateral Meniere's disease09/03/2019
- Overproduction of Gentamicin (cas 1403-66-3) B in industrial strain Micromonospora echinospora CCTCC M 2018898 by cloning of the missing genes genR and genS09/02/2019
- Original ArticleStandard-dose Gentamicin (cas 1403-66-3) does not increase risk of patent ductus arteriosus09/01/2019


